Editorial: Role of Neuroinflammation in the Neuropsychiatric and Neurological Aspects of COVID-19
Front. Cell. Neurosci.. 2022-02-09; 16:
DOI: 10.3389/fncel.2022.840121
Lire sur PubMed
Tremblay ME(1)(2)(3)(4)(5), Madore C(6), Tian L(7)(8), Verkhratsky A(9)(10)(11)(12).
Author information:
(1)Axe Neurosciences, Centre de Recherche du CHU de Québec, Université Laval,
Québec City, QC, Canada.
(2)Neurology and Neurosurgery Department, McGill University, Montréal, QC,
Canada.
(3)Department of Molecular Medicine, Université Laval, Québec City, QC, Canada.
(4)Division of Medical Sciences, University of Victoria, Victoria, BC, Canada.
(5)Department of Biochemistry and Molecular Biology, The University of British
Columbia, Vancouver, BC, Canada.
(6)Univ. Bordeaux, INRAE, Bordeaux INP, NutriNeuro, UMR 1286, Bordeaux, France.
(7)Department of Physiology, Faculty of Medicine, Institute of Biomedicine and
Translational Medicine, University of Tartu, Tartu, Estonia.
(8)Psychiatry Research Centre, Beijing Huilongguan Hospital, Peking University
Health Science Center, Beijing, China.
(9)Faculty of Biology, Medicine and Health, The University of Manchester,
Manchester, United Kingdom.
(10)Achucarro Center for Neuroscience, IKERBASQUE, Basque Foundation for
Science, Bilbao, Spain.
(11)Department of Neurosciences, University of the Basque Country UPV/EHU and
CIBERNED, Leioa, Spain.
(12)Sechenov First Moscow State Medical University, Moscow, Russia.
Comment on
Editorial on the Research Topic Role of Neuroinflammation in the
Neuropsychiatric and Neurological Aspects of COVID-19.
DOI: 10.3389/fncel.2022.840121
PMCID: PMC8863733
PMID: 35221927
Conflict of interest statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.